3,510
Views
8
CrossRef citations to date
0
Altmetric
Research Paper

A Japanese nationwide survey of 23-valent pneumococcal capsular polysaccharide vaccine (PPSV23) coverage among patients with chronic medical condition aged 50 and older

, , , &
Pages 1521-1528 | Received 02 Sep 2019, Accepted 04 Nov 2019, Published online: 04 Dec 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Miwa Haranaka, Makoto Yono, Hiroyuki Kishino, Rie Igarashi, Nobuyuki Oshima, Miyuki Sawata & Heather Loryn Platt. (2023) Safety, tolerability, and immunogenicity of a 21-valent pneumococcal conjugate vaccine, V116, in Japanese healthy adults: A Phase I study. Human Vaccines & Immunotherapeutics 19:2.
Read now
Eman Y. Abu-rish & Noor A. Barakat. (2021) The impact of pharmacist-led educational intervention on pneumococcal vaccine awareness and acceptance among elderly in Jordan. Human Vaccines & Immunotherapeutics 17:4, pages 1181-1189.
Read now
Yasuhiro Tanaka, Kazuko Yamamoto, Yuichi Fukuda, Asuka Umemura, Masataka Yoshida, Shuhei Ideguchi, Nobuyuki Ashizawa, Tatsuro Hirayama, Masato Tashiro, Takahiro Takazono, Yoshifumi Imamura, Taiga Miyazaki, Koichi Izumikawa, Katsunori Yanagihara, Bin Chang & Hiroshi Mukae. (2020) An adult case of invasive pneumococcal disease due to serotype 12F-specific polysaccharide antibody failure following a 23-valent polysaccharide vaccination. Emerging Microbes & Infections 9:1, pages 2266-2268.
Read now

Articles from other publishers (5)

Takeshi Tanaka, Satoshi Kakiuchi, Masato Tashiro, Ayumi Fujita, Nobuyuki Ashizawa, Susumu Eguchi, Takashi Kenmochi, Hiroto Egawa & Koichi Izumikawa. (2023) Adherence to recommended vaccination policies for pre- and post-solid organ transplantation patients: A national questionnaire survey in Japan. Vaccine 41:52, pages 7682-7688.
Crossref
Shirley Shapiro Ben David, Orna Shamai-Lubovitz, Vered Mourad, Iris Goren, Erica Cohen Iunger, Tamar Alcalay, Angela Irony, Shira Greenfeld, Limor Adler & Amos Cahan. (2023) A Nationwide Digital Multidisciplinary Intervention Aimed at Promoting Pneumococcal Vaccination in Immunocompromised Patients. Vaccines 11:8, pages 1355.
Crossref
Shiori Tanaka, Manami Inoue, Taiki Yamaji, Motoki Iwasaki, Tetsuji Minami, Shoichiro Tsugane & Norie Sawada. (2022) Increased risk of death from pneumonia among cancer survivors: A propensity score‐matched cohort analysis. Cancer Medicine 12:6, pages 6689-6699.
Crossref
E. A. Orlova, I. P. Dorfman, O. V. Shatalova, M. A. Orlov, R. M. Mamina & N. N. Mochalova. (2022) The Reality and Prospects of Pneumococcal Vaccination during the COVID-19 Pandemic. Epidemiology and Vaccinal Prevention 21:5, pages 89-97.
Crossref
Shigeo Hanada, Misako Takata, Miyuki Morozumi, Satoshi Iwata, Seitaro Fujishima & Kimiko Ubukata. (2021) Multiple comorbidities increase the risk of death from invasive pneumococcal disease under the age of 65 years. Journal of Infection and Chemotherapy 27:9, pages 1311-1318.
Crossref